APC and cancer: Future work will focus on defining the contexts in which TFAP4 regulates WNT transcriptional responses under physiological and pathological conditions, given that its site of action downstream of the CTNNB1 destruction complex could be favorable for therapeutic intervention in cancers where WNT signaling is activated by loss of APC or by mutations that stabilize CTNNB1.